I am a physician-scientist interested in translational development of immunotherapeutic strategies for cancer. Specifically, my laboratory is focused on developing chimeric antigen receptor T-cell therapy approaches against novel targets for hematological and solid tumor malignancies and to develop novel allogeneic T-cell therapy strategies.